Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
A focused evaluation asks which retirement index fund—Total Market or Sp 500—better fits long-term goals, balancing fees, risk, and growth potential.
28,526 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Offerpad rolls out two internal AI platforms, SCOUT and HENRY, as the company pursues 1,000 quarterly home transactio...
The Federal Trade Commission sent a formal warning to Mortgage Connect over its use of noncompete agreements, citing ...
A small cadre of high-priced stocks stubbornly resist stock splits even as peers embrace them. Here are four names le...
The House Ways and Means Committee plans a June hearing to decide if crypto tax relief should cover more than stablec...
Palantir tumbles about 7% midday as Palo Alto Networks and CrowdStrike hold steadier, raising questions about governm...
Apple stock is trading in the high 300s as traders weigh a possible rally. Here are three catalysts that could push a...
After a quarterly report, Netflix's post-earnings sell-off just highlighted a shift in strategy. This article breaks ...
NVIDIA is expected to report a $65.7 billion Q4 revenue figure as investors weigh margin recovery against AI-driven d...
West Capital Lending filed a federal lawsuit in California accusing LoanDepot of a sweeping pay scheme tied to loan o...
Aster broadens its partnership with WLFI to introduce USD1-denominated perpetual contracts and new incentives, design...
Qualcomm is betting big on non-phone AI devices, teaming with top AI firms to power wearables that act as autonomous ...